Is Spruce Biosciences, Inc. (SPRB) a Buy, Sell, or Hold?
NASDAQ : SPRB
Spruce Biosciences, Inc. — Analyst Ratings
$46.7 USD
$0.29 (0.62%)
- Volume
- 16.94K
- Average Volume
- 70.76K
- Market Capitalization
- $128.53M
- P/E Ratio
- -1.14
- Dividend Yield
- 0.00%
- Price Target
- $140.00
- Year High
- $240.00
- Year Low
- $7.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.23
Analyst Consensus Summary
Consensus Rating
Neutral
11 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-66.6%
vs Current Price
Price Target
$140.00
Average TargetPrice Target Range
Lowest Target
$123.00
-62.0% DOWNSIDE
Average Target
$140.00
Median Estimate
Highest Target
$150.00
-68.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 5 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Debjit Chattopadhyay | $123 | $49.905 | 2026-06-16 06:40 AM | 146.5% |
| Craig-Hallum | Albert Lowe | $140 | $55.63 | 2026-04-27 08:05 AM | 151.7% |